6-98926884-A-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001278716.2(FBXL4):​c.105T>A​(p.His35Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0293 in 1,614,076 control chromosomes in the GnomAD database, including 775 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 59 hom., cov: 32)
Exomes 𝑓: 0.030 ( 716 hom. )

Consequence

FBXL4
NM_001278716.2 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.159
Variant links:
Genes affected
FBXL4 (HGNC:13601): (F-box and leucine rich repeat protein 4) This gene encodes a member of the F-box protein family, which are characterized by an approximately 40 amino acid motif, the F-box. F-box proteins constitute one subunit of modular E3 ubiquitin ligase complexes, called SCF complexes, which function in phosphorylation-dependent ubiquitination. The F-box domain mediates protein-protein interactions and binds directly to S-phase kinase-associated protein 1. In addition to an F-box domain, the encoded protein contains at least 9 tandem leucine-rich repeats. The ubiquitin ligase complex containing the encoded protein may function in cell-cycle control by regulating levels of lysine-specific demethylase 4A. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030468106).
BP6
Variant 6-98926884-A-T is Benign according to our data. Variant chr6-98926884-A-T is described in ClinVar as [Benign]. Clinvar id is 260207.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-98926884-A-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0231 (3510/152230) while in subpopulation NFE AF= 0.0355 (2417/67998). AF 95% confidence interval is 0.0344. There are 59 homozygotes in gnomad4. There are 1608 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 59 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FBXL4NM_001278716.2 linkuse as main transcriptc.105T>A p.His35Gln missense_variant 4/10 ENST00000369244.7 NP_001265645.1 Q9UKA2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FBXL4ENST00000369244.7 linkuse as main transcriptc.105T>A p.His35Gln missense_variant 4/101 NM_001278716.2 ENSP00000358247.1 Q9UKA2
FBXL4ENST00000229971.2 linkuse as main transcriptc.105T>A p.His35Gln missense_variant 3/91 ENSP00000229971.1 Q9UKA2

Frequencies

GnomAD3 genomes
AF:
0.0231
AC:
3510
AN:
152112
Hom.:
59
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00739
Gnomad AMI
AF:
0.0471
Gnomad AMR
AF:
0.0265
Gnomad ASJ
AF:
0.0505
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00373
Gnomad FIN
AF:
0.00896
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0356
Gnomad OTH
AF:
0.0230
GnomAD3 exomes
AF:
0.0220
AC:
5523
AN:
251384
Hom.:
86
AF XY:
0.0225
AC XY:
3058
AN XY:
135864
show subpopulations
Gnomad AFR exome
AF:
0.00572
Gnomad AMR exome
AF:
0.0180
Gnomad ASJ exome
AF:
0.0453
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00464
Gnomad FIN exome
AF:
0.0123
Gnomad NFE exome
AF:
0.0333
Gnomad OTH exome
AF:
0.0256
GnomAD4 exome
AF:
0.0300
AC:
43863
AN:
1461846
Hom.:
716
Cov.:
32
AF XY:
0.0296
AC XY:
21509
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.00490
Gnomad4 AMR exome
AF:
0.0185
Gnomad4 ASJ exome
AF:
0.0455
Gnomad4 EAS exome
AF:
0.000126
Gnomad4 SAS exome
AF:
0.00508
Gnomad4 FIN exome
AF:
0.0116
Gnomad4 NFE exome
AF:
0.0348
Gnomad4 OTH exome
AF:
0.0296
GnomAD4 genome
AF:
0.0231
AC:
3510
AN:
152230
Hom.:
59
Cov.:
32
AF XY:
0.0216
AC XY:
1608
AN XY:
74440
show subpopulations
Gnomad4 AFR
AF:
0.00739
Gnomad4 AMR
AF:
0.0264
Gnomad4 ASJ
AF:
0.0505
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00373
Gnomad4 FIN
AF:
0.00896
Gnomad4 NFE
AF:
0.0355
Gnomad4 OTH
AF:
0.0227
Alfa
AF:
0.0324
Hom.:
68
Bravo
AF:
0.0244
TwinsUK
AF:
0.0353
AC:
131
ALSPAC
AF:
0.0366
AC:
141
ESP6500AA
AF:
0.00658
AC:
29
ESP6500EA
AF:
0.0349
AC:
300
ExAC
AF:
0.0214
AC:
2598
Asia WGS
AF:
0.00549
AC:
19
AN:
3478
EpiCase
AF:
0.0395
EpiControl
AF:
0.0385

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxJan 07, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:2
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicDec 29, 2017- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Mitochondrial DNA depletion syndrome 13 Benign:1
Benign, criteria provided, single submitterreference populationWong Mito Lab, Molecular and Human Genetics, Baylor College of MedicineAug 10, 2017The NM_012160.4:c.105T>A (NP_036292.2:p.His35Gln) [GRCH38: NC_000006.12:g.98926884A>T] variant in FBXL4 gene is interpretated to be a Benign based on ACMG guidelines (PMID: 25741868). This variant meets one or more of the following evidence codes reported in the ACMG-guideline. BS1:The minor allele frequency of this allele is high for Mitochondrial DNA depletion syndrome 13. BS2:Observation of the variant is in controls is inconsistent with penetrance of Mitochondrial DNA depletion syndrome 13. BP4:Computational evidence/predictors indicate no impact on the FBXL4 structure, function, or protein-protein interaction. Based on this evidence code ClinGen Pathogenicity Calculator (PMID:28081714) suggested that the variant is Benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.70
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
17
DANN
Benign
0.96
DEOGEN2
Benign
0.024
T;T
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.20
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.83
.;T
MetaRNN
Benign
0.0030
T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
0.0
N;N
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.14
N;N
REVEL
Benign
0.069
Sift
Benign
0.15
T;T
Sift4G
Uncertain
0.036
D;D
Polyphen
0.090
B;B
Vest4
0.066
MutPred
0.33
Loss of helix (P = 0.0033);Loss of helix (P = 0.0033);
MPC
0.069
ClinPred
0.011
T
GERP RS
4.4
Varity_R
0.13
gMVP
0.44

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34316889; hg19: chr6-99374760; API